Susquehanna International Group
KRSA

Susquehanna International Group’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Susquehanna International Group’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-99
Closed -$24K – 13124
2021
Q4 		$24K Sell
99
-27
-21% -$1.27K ﹤0.01% 12791
2021
Q3 		$54K Sell
126
-154
-55% -$10.1K ﹤0.01% 12324
2021
Q2 		$153K Buy
280
+36
+15% +$2.25K ﹤0.01% 11839
2021
Q1 		$95K Buy
244
+148
+154% +$11.1K ﹤0.01% 11884
2020
Q4 		$41K Buy
+96
New +$6.54K ﹤0.01% 10793

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group's KRSA Position: Q2 2023 in Review

Susquehanna International Group sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 323 shares — an estimated $11.7K sold.

Susquehanna International Group first reported a position in KRSA in Q2 2019 and held it in 14 quarters. The position peaked at $313K in Q2 2021. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

  • Susquehanna International Group reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 323 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $11.7K.
  • Susquehanna International Group first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Susquehanna International Group's Korsana Biosciences, Inc. Common Stock position peaked at $313K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.